1985
DOI: 10.1016/0002-9149(85)90748-9
|View full text |Cite
|
Sign up to set email alerts
|

Coronary artery spasm after abrupt withdrawal of nitroglycerin in rabbits

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
7
1

Year Published

1987
1987
2006
2006

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 14 publications
1
7
1
Order By: Relevance
“…Experiments carried out in rabbits also demonstrated coronary spasm upon discontinuation of nitroglycerin (30). The results from the present investigation differ from those earlier studies.…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…Experiments carried out in rabbits also demonstrated coronary spasm upon discontinuation of nitroglycerin (30). The results from the present investigation differ from those earlier studies.…”
Section: Discussioncontrasting
confidence: 99%
“…One of these patients manifested the symptoms2 days after discontinuation of ISDN, and 2 patients developed coronary spasm. These results appear to be noteworthy in relation to the reports cited above (29,30).…”
Section: Discussionsupporting
confidence: 83%
“…Reflex neurohumoral activation initiated by nitrates might play a role in increasing cardiac events [18, 20, 21]. Abrupt withdrawal of nitroglycerin and subsequent administration of ergonovine and indomethacin probably induces the coronary artery spasm which causes myocardial ischemia, ventricular arrhythmia and myocardial infarction [22, 23]. …”
Section: Discussionmentioning
confidence: 99%
“…When we compared the rate of change in coronary blood velocity after sublingual nitroglycerin among the 3 groups, APV in the continuous dosing group decreased by 13±6% of the pretreatment value, whereas the rates of decrease were 32±5% in the eccentric dosing group and 39±6% in the untreated group, suggesting the appearance of tolerance in the continuous dosing group. The limitations of eccentric dosing of nitrates include a rebound phenomenon related to a decrease in the blood concentration of nitrates, and this phenomenon has been experimentally and clinically reported as deterioration of anginal symptoms or coronary stenosis related to discontinuation of nitrates (18)(19)(20)(21). Eccentric dosing does not prevent cardiac events (22)(23)(24).…”
Section: Tolerance To Nitratesmentioning
confidence: 99%